Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-223882
Filing Date
2012-05-10
Accepted
2012-05-10 09:01:04
Documents
13
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d342363d10q.htm 10-Q 435976
2 EX-10.1 d342363dex101.htm EX-10.1 4458
3 EX-31.1 d342363dex311.htm EX-31.1 10143
4 EX-31.2 d342363dex312.htm EX-31.2 10346
5 EX-32.1 d342363dex321.htm EX-32.1 4735
6 EX-32.2 d342363dex322.htm EX-32.2 4757
13 GRAPHIC g342363g69f18.jpg GRAPHIC 27949
  Complete submission text file 0001193125-12-223882.txt   1745030

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT somx-20120331.xml EX-101.INS 188895
8 XBRL TAXONOMY EXTENSION SCHEMA somx-20120331.xsd EX-101.SCH 9272
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE somx-20120331_cal.xml EX-101.CAL 25909
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE somx-20120331_def.xml EX-101.DEF 7412
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE somx-20120331_lab.xml EX-101.LAB 96695
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE somx-20120331_pre.xml EX-101.PRE 63634
Mailing Address 10935 VISTA SORRENTO PARKWAY SUITE 250 SAN DIEGO CA 92130
Business Address 10935 VISTA SORRENTO PARKWAY SUITE 250 SAN DIEGO CA 92130 (858) 876-6500
Somaxon Pharmaceuticals, Inc. (Filer) CIK: 0001339455 (see all company filings)

EIN.: 200161599 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51665 | Film No.: 12827909
SIC: 2834 Pharmaceutical Preparations